Business
Claritev Corporation Reports First Quarter 2025 Results
MCLEAN, Va., May 08, 2025--Claritev Corporation Reports First Quarter 2025 Results
About this update from Claritev Corporation
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1342,"height":250,"url":"https://media.zenfs.com/en/business-wire.com/3da1a9012c428008b8e68799960aa866"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/.jcTJpOL8XdqQJGcmMQinQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTE3OTtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/3da1a9012c428008b8e68799960aa866","width":960,"height":179},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/eUmTggvDX2nKtIaqgGfn3Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD00NDg7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/3da1a9012c428008b8e68799960aa866","width":1200,"height":224}},"lazy":false},{"type":"text","content":"– Q1 2025 Revenues of $231.3 million, Net Loss of $71.3 million, and Adjusted EBITDA of $142.1 million (Adjusted EBITDA Margin of 61.4%)","length":136,"tagName":"p"},{"type":"text","content":"– Reaffirms full-year guidance","length":30,"tagName":"p"},{"type":"text","content":"MCLEAN, Va., May 08, 2025--(BUSINESS WIRE)--Claritev Corporation ("Claritev" or the "Company") (NYSE: CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today reported financial results for the first quarter ended March 31, 2025.","length":321,"tagName":"p"},{"type":"text","content":""There is tremendous excitement at Claritev as we kick off 2025 - our ‘Year of The Turn.’ We’ve already announced major milestones, and our teams are amplifying this positive momentum as we continue on our planned course for the year," said Travis Dalton, Chairman, CEO and President of Claritev.","length":306,"tagName":"p"},{"type":"text","content":""Already in 2025, we’ve made advances on our key objectives by completing our debt extension, launching our full rebranding to Claritev, and forming strategic alliances with Oracle (leveraging its Oracle Cloud Infrastructure and Oracle Cloud Marketplace), J2 Health (supporting our network development strategy including those related to the Medicare Advantage program), and most recently, Burjeel Holdings, with whom we intend to expand Claritev’s footprint globally. These achievements will continue to build with our recent successful recruitment of our new Chief Medical Officer, Chief AI Officer, and...